We narrowed to 8,882 results for: plat

1. pTR-450 tNGFR-P2A-CXCR4

   Plasmid

   #186078

   Purpose

   Knockin of truncated NGFR to target gene

   Depositor

   Alexander Marson

   Article

   Shy et al Nat Biotechnol. 2022 Aug 25:10.1038/s415

   Insert

   CXCR4 (CXCR4 Human)
   

   Use

   CRISPR

   Mutation

   WT with tNGFR sequence

   Available Since

   July 28, 2022

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

2. pTR-454 tNGFR-P2A-CARD11

   Plasmid

   #186081

   Purpose

   Knockin of truncated NGFR to target gene

   Depositor

   Alexander Marson

   Article

   Shy et al Nat Biotechnol. 2022 Aug 25:10.1038/s415

   Insert

   CARD11 (CARD11 Human)
   

   Use

   CRISPR

   Mutation

   WT with tNGFR sequence

   Available Since

   July 28, 2022

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

3. pTR-456 tNGFR-P2A-ITGB1

   Plasmid

   #186083

   Purpose

   Knockin of truncated NGFR to target gene

   Depositor

   Alexander Marson

   Article

   Shy et al Nat Biotechnol. 2022 Aug 25:10.1038/s415

   Insert

   ITGB1 (ITGB1 Human)
   

   Use

   CRISPR

   Mutation

   WT with tNGFR sequence

   Available Since

   July 28, 2022

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

4. pTR-378 tNGFR-P2A-CCR7

   Plasmid

   #186072

   Purpose

   Knockin of truncated NGFR to target gene

   Depositor

   Alexander Marson

   Article

   Shy et al Nat Biotechnol. 2022 Aug 25:10.1038/s415

   Insert

   CCR7 (CCR7 Human)
   

   Use

   CRISPR

   Mutation

   WT with tNGFR sequence

   Available Since

   July 28, 2022

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

5. pTR-337 pUC19-tNGFR-P2A-CTLA4 N

   Plasmid

   #186054

   Purpose

   Knockin of truncated NGFR to target gene

   Depositor

   Alexander Marson

   Article

   Shy et al Nat Biotechnol. 2022 Aug 25:10.1038/s415

   Insert

   CTLA4 (CTLA4 Human)
   

   Use

   CRISPR

   Mutation

   WT with tNGFR sequence

   Available Since

   July 28, 2022

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

6. pTR-457 tNGFR-P2A-STAT1

   Plasmid

   #186059

   Purpose

   Knockin of truncated NGFR to target gene

   Depositor

   Alexander Marson

   Article

   Shy et al Nat Biotechnol. 2022 Aug 25:10.1038/s415

   Insert

   STAT1 (STAT1 Human)
   

   Use

   CRISPR

   Mutation

   WT with tNGFR sequence

   Available Since

   July 28, 2022

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

7. pTR-473 FOXP1-tNGFR

   Plasmid

   #186063

   Purpose

   Knockin of truncated NGFR to target gene

   Depositor

   Alexander Marson

   Article

   Shy et al Nat Biotechnol. 2022 Aug 25:10.1038/s415

   Insert

   FOXP1 (FOXP1 Human)
   

   Use

   CRISPR

   Mutation

   WT with tNGFR sequence

   Available Since

   July 28, 2022

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

8. Anti-TRIP8b (exon 1b) [N212A/34R]

   Plasmid

   #182108

   Purpose

   Mammalian Expression Plasmid of anti-TRIP8b (exon 1b) (Mouse). Derived from hybridoma N212A/34.

   Depositor

   James Trimmer

   Article

   Mitchell et al Sci Rep. 2023 Sep 27;13(1):16200. doi: 1

   Insert

   anti-TRIP8b (exon 1b) (Mus musculus) recombinant mouse monoclonal antibody (Pex5l Mouse)
   

   Expression

   Mammalian

   Promoter

   Dual CMV

   Available Since

   June 1, 2022

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

9. Anti-LRRTM2 [N209C/35R]

   Plasmid

   #182107

   Purpose

   Mammalian Expression Plasmid of anti-LRRTM2 (Human). Derived from hybridoma N209C/35.

   Depositor

   James Trimmer

   Article

   Mitchell et al Sci Rep. 2023 Sep 27;13(1):16200. doi: 1

   Insert

   anti-LRRTM2 (Homo sapiens) recombinant mouse monoclonal antibody (LRRTM2 Mouse)
   

   Expression

   Mammalian

   Promoter

   Dual CMV

   Available Since

   June 1, 2022

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

10. Arl13b scFv [N295B/66]

    Plasmid

    #182086

    Purpose

    Mammalian Expression of Arl13b scFv. Derived from hybridoma N295B/66.

    Depositor

    James Trimmer

    Article

    Mitchell et al Sci Rep. 2023 Sep 27;13(1):16200. doi: 1

    Insert

    recombinant mouse scFv targeting Arl13b (Mus musculus) (Arl13b Mouse)
    

    Tags

    HA, His

    Expression

    Mammalian

    Promoter

    CMV

    Available Since

    March 25, 2022

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

11. RGS14 scFv [N133/21]

    Plasmid

    #182081

    Purpose

    Mammalian Expression of RGS14 scFv. Derived from hybridoma N133/21.

    Depositor

    James Trimmer

    Article

    Mitchell et al Sci Rep. 2023 Sep 27;13(1):16200. doi: 1

    Insert

    recombinant mouse scFv targeting RGS14 (Rattus norvegicus) (Rgs14 Mouse)
    

    Tags

    Sortase, His

    Expression

    Mammalian

    Promoter

    CMV

    Available Since

    March 25, 2022

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

12. Kv2.1 K+ channel scFv [K89/34]

    Plasmid

    #182069

    Purpose

    Mammalian Expression of Kv2.1 K+ channel scFv. Derived from hybridoma K89/34.

    Depositor

    James Trimmer

    Article

    Mitchell et al Sci Rep. 2023 Sep 27;13(1):16200. doi: 1

    Insert

    recombinant mouse scFv targeting Kv2.1 K+ channel (Rattus norvegicus) (Kcnb1 Mouse)
    

    Tags

    HA, His

    Expression

    Mammalian

    Promoter

    CMV

    Available Since

    March 24, 2022

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

13. Anti-NPY2R [L119/106R]

    Plasmid

    #177464

    Purpose

    Mammalian Expression Plasmid of anti-NPY2R/Neuropeptide Y receptor type 2 (Human). Derived from hybridoma L119/106.

    Depositor

    James Trimmer

    Article

    Mitchell et al Sci Rep. 2023 Sep 27;13(1):16200. doi: 1

    Insert

    anti-NPY2R/Neuropeptide Y receptor type 2 (Homo sapiens) recombinant mouse monoclonal antibody (NPY2R Mouse)
    

    Expression

    Mammalian

    Promoter

    Dual CMV

    Available Since

    Jan. 18, 2022

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

14. Anti-Rufy3 [N483/84R]

    Plasmid

    #177558

    Purpose

    Mammalian Expression Plasmid of anti-Rufy3 (Mouse). Derived from hybridoma N483/84.

    Depositor

    James Trimmer

    Article

    Mitchell et al Sci Rep. 2023 Sep 27;13(1):16200. doi: 1

    Insert

    anti-Rufy3 (Mus musculus) recombinant mouse monoclonal antibody (Rufy3 Mouse)
    

    Expression

    Mammalian

    Promoter

    Dual CMV

    Available Since

    Jan. 6, 2022

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

15. Anti-RBM17/SPF45 [N219/5R]

    Plasmid

    #177515

    Purpose

    Mammalian Expression Plasmid of anti-RBM17/SPF45 (Human). Derived from hybridoma N219/5.

    Depositor

    James Trimmer

    Article

    Mitchell et al Sci Rep. 2023 Sep 27;13(1):16200. doi: 1

    Insert

    anti-RBM17/SPF45 (Homo sapiens) recombinant mouse monoclonal antibody (RBM17 Mouse)
    

    Expression

    Mammalian

    Promoter

    Dual CMV

    Available Since

    Jan. 6, 2022

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

16. Anti-Pan-Gamma-protocadherin-Constant [N159/5R]

    Plasmid

    #177503

    Purpose

    Mammalian Expression Plasmid of anti-Pan-Gamma-protocadherin-Constant (Mouse). Derived from hybridoma N159/5.

    Depositor

    James Trimmer

    Article

    Mitchell et al Sci Rep. 2023 Sep 27;13(1):16200. doi: 1

    Insert

    anti-Pan-Gamma-protocadherin-Constant (Mus musculus) recombinant mouse monoclonal antibody
    

    Expression

    Mammalian

    Promoter

    Dual CMV

    Available Since

    Jan. 6, 2022

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

17. Anti-Mad3 [N129/15R]

    Plasmid

    #177498

    Purpose

    Mammalian Expression Plasmid of anti-Mad3 (Homo sapiens) (Human). Derived from hybridoma N129/15.

    Depositor

    James Trimmer

    Article

    Mitchell et al Sci Rep. 2023 Sep 27;13(1):16200. doi: 1

    Insert

    anti-Mad3 (Homo sapiens) recombinant mouse monoclonal antibody (MXD3 Mouse)
    

    Expression

    Mammalian

    Promoter

    Dual CMV

    Available Since

    Jan. 6, 2022

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

18. Anti-Rufy3 [N483/126R]

    Plasmid

    #177556

    Purpose

    Mammalian Expression Plasmid of anti-Rufy3 (Mouse). Derived from hybridoma N483/126.

    Depositor

    James Trimmer

    Article

    Mitchell et al Sci Rep. 2023 Sep 27;13(1):16200. doi: 1

    Insert

    anti-Rufy3 (Mus musculus) recombinant mouse monoclonal antibody (Rufy3 Mouse)
    

    Expression

    Mammalian

    Promoter

    Dual CMV

    Available Since

    Nov. 29, 2021

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

19. Anti-Rufy3 [N483/26R]

    Plasmid

    #177557

    Purpose

    Mammalian Expression Plasmid of anti-Rufy3 (Mouse). Derived from hybridoma N483/26.

    Depositor

    James Trimmer

    Article

    Mitchell et al Sci Rep. 2023 Sep 27;13(1):16200. doi: 1

    Insert

    anti-Rufy3 (Mus musculus) recombinant mouse monoclonal antibody (Rufy3 Mouse)
    

    Expression

    Mammalian

    Promoter

    Dual CMV

    Available Since

    Nov. 23, 2021

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

20. Anti-BAF53b [N332B/15R]

    Plasmid

    #177533

    Purpose

    Mammalian Expression Plasmid of anti-BAF53b (Human). Derived from hybridoma N332B/15.

    Depositor

    James Trimmer

    Article

    Mitchell et al Sci Rep. 2023 Sep 27;13(1):16200. doi: 1

    Insert

    anti-BAF53b (Homo sapiens) recombinant mouse monoclonal antibody (Actl6b Mouse)
    

    Expression

    Mammalian

    Promoter

    Dual CMV

    Available Since

    Nov. 23, 2021

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge